BeyondSpring updates Plinabulin data, names new CEO, reports Q2 2026 resultsAug 14Quarterly updateBeyondSpring Pharmaceuticals Inc.
Datroway wins EU approval for first-line metastatic TNBCJul 31Regulatory decisionAstraZenecadatopotamab deruxtecan
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyJul 23Weekly roundup, 5 itemsAstraZenecaAZD6489
CHMP backs Datroway for first-line TNBC treatment in EUJun 29Regulatory milestoneAstraZenecadatopotamab deruxtecan
Sign inSign in